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Analysis of the effects of increasing delivered dialysis
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and GAVIN I. RUSSELL
Department of Nephrology, North Staffordshire Hospital Trust, Stoke-on-Trent, United Kingdom
that malnutrition is acquired on PD in those patients who loseAnalysis of the effects of increasing delivered dialysis treatment
residual renal function. It is feasible to increase the dialysisto malnourished peritoneal dialysis patients.
dose in these individuals without a detrimental effect, and thereBackground. Poor nutrition is associated with a loss of resid-
is evidence of a modest benefit in patients without comorbidity.ual renal function and inferior clinical outcome in peritoneal
dialysis (PD) patients. The value of increasing the PD dose in
these individuals is unclear.
Methods. An open, prospective, longitudinal, “intention to
Indices of poor nutrition are important predictors oftreat” study was performed on a whole PD population. All
survival in patients treated with peritoneal dialysis (PD)patients treated during an 18-month recruitment period under-
went nutritional assessment and were defined as malnourished [1, 2]. There is now compelling evidence, from both cross-
if they had a subjective global assessment (SGA) of B or C sectional and longitudinal studies [3–5], that following
and were 5% or more below their desirable body weight. These some initial improvement, there is a decline in nutritionalpatients received an intended dialysis dose increase of 25% and
state with time on treatment. This deterioration appearswere reassessed after six months. Dialysis was not increased in
the remaining patients, unless dictated by uremic symptoms. to parallel the loss in residual renal function that occurs
Results. Forty-eight of 153 patients were malnourished by with time, and has been documented most clearly in
the previously mentioned criteria. When compared with well- studies in which no systematic attempt has been made
nourished PD patients, they had evidence of declining nutrition
to compensate for this loss [4, 5]. These observationsover the previous 12 months, as judged by a loss in body weight
have led to the development of guidelines in which theand mid-arm circumference (MAC), a reduced creatinine ap-
pearance, a reduced appetite for protein and calories, and low clinician is encouraged to increase the delivered dialysis
plasma albumin. They had been on treatment longer and had dose, primarily to achieve increased solute clearance,
less residual renal function, resulting in significantly poorer in the hope of preventing or at least ameliorating thesolute clearances. Their peritoneal membrane function, plasma
development of malnutrition [6, 7].bicarbonate, comorbid, Karnofsky, Hospital Anxiety and De-
The advantage to the patient of increasing deliveredpression (HAD) scores were not different. Following interven-
tion, their peritoneal Kt/Vurea was increased by 22.5%, and their dialysis dose is less clear, particularly when there is al-
total Kt/Vurea by 18%, because of a continued loss of residual ready evidence of malnutrition. A number of studies
function. There was also an increase in dialysis-derived calories.
examining the influence of increasing Kt/V on nutritionalWeight and MAC stabilized after an initial deterioration, and
parameters have been published, and these illustrate thecreatinine appearance increased. There was no increase in pro-
tein intake, as judged by dietetic interview or protein nitrogen difficulties that may be encountered in studying this
appearance. Oral calorie intake improved, as did plasma albu- problem. Concerns about the true relationship between
min after an initial decline. Both of these improvements were protein nitrogen appearance (PNA) and Kt/V, whichcorrelated with the achieved increase in Kt/Vurea. Objective mea-
exhibit mathematical coupling in cross-sectional studiessures of improvement (plasma albumin and protein nitrogen
[8], have led some researchers to establish that a riseappearance) were significant in those patients without comor-
bid disease. in PNA does accompany an increase in Kt/V [9, 10].
Conclusions. These results support the existing evidence However, these studies are too small and of insufficient
duration to establish an effect on nutritional state, and
are still confounded to some extent by the coupling ef-Key words: malnutrition, dialysis dose, appetite, subjective global as-
sessment, Stoke PD Study. fect. Other studies have taken the baseline Kt/V rather
than the nutritional state of the patient as their selection
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suboptimal nutrition at the start of the study. Another were judged as malnourished (Group 1) if their SGA
problem, encountered by the only comparative study was B or worse and they were 5% below their desirable
in the literature, is the continued loss of residual renal weight. If only one of these criteria was fulfilled, then
function [12]. This meant that these investigators failed enrollment was postponed for six months, by which time
to achieve a net increase in total solute clearance in the it was clear whether nutrition was improving or deterio-
intervention group. Finally, these studies have tended to rating. Those patients assessed as being adequately nour-
concentrate on a fairly narrow assessment of nutrition, ished were designated as Group 2. A small number of
namely the ability of increased solute clearance to alter well-nourished patients complained of uremic symptoms
dietary protein intake, often expressed as PNA. In prac- that might be considered to improve following an in-
tice, however, increasing the dialysis dose in PD patients crease in dialysis dose. To preserve clinical freedom
results in an obligatory increase in dialysis-derived calo- within the study, the clinician was able to increase the
ries and is unlikely to have any significant impact unless delivered dialysis dose to these individuals, who were
accompanied by dietetic support and advice. Thus, it is essentially self-defining and were designated as Group
the alteration in a package of treatment care that needs 3. No patient, throughout the study period, had increases
to be evaluated. in the delivered dialysis dose simply to achieve clearance
In designing the present study, we have attempted to targets. As one of the purposes of the study was to
anticipate as many of these problems as possible. We establish the feasibility of this clinical approach, patient
aimed to recruit 50 patients, selected from our whole education and involvement were crucial. Patients were,
PD population, which is described in its totality, using however, at liberty to decline the intervention or to re-
predefined criteria for undernutrition. To minimize the quest transfer to hemodialysis throughout the study pe-
limitations of performing an open study, prospectively
riod and follow-up, which was six months.
gathered data from the preintervention period and paral-
The outcome variables were actual weight and mid-lel data from the well-nourished patients are shown. The
arm circumference (MAC), SGA, urea and creatinineintervention was planned to achieve a 25% increase in
kinetics, dietary protein and calorie intake, total calorieKt/Vurea. Assessment of nutritional state includes appetite intake (TCI), and plasma albumin. A number of addi-for protein and calories, anthropometrics, urea, and cre-
tional clinical measurements were also collected, primar-atinine kinetics, and it also takes into account the dial-
ily to assist in the interpretation of results. These in-ysis-derived calories.
cluded a sum of comorbid conditions, in-patient days,
peritoneal membrane function [peritoneal equilibration
METHODS test (PET)] and achieved net ultrafiltration, plasma bi-
carbonate as a measure of acid-base status, the Karnof-Study design and patient recruitment
sky score as an index of physical state, and the hospitalThis was an open, prospective, “intention-to-treat,”
anxiety and depression scores (HAD) as indices of men-longitudinal intervention study, performed in a whole
tal state.PD population in whom the selection criteria for under-
nutrition were carefully defined. The Stoke PD Study,
Urea and creatinine kineticsdescribed elsewhere in detail [5], is a longitudinal pro-
These were measured every six months in all patientsspective cohort study of PD patients that commenced at
to assess solute clearance (Kt/Vurea), PNA, and lean bodyour institution in 1990. Until the end of 1995, when the
data were censored, this was a purely observational mass (creatinine kinetics). In each case, the kinetics were
study, with particular emphasis on nutrition and perito- calculated from the 24-hour urinary and dialysate re-
neal membrane function that were assessed every six moval by direct measurement of urea and creatinine in
months, thus providing prospectively gathered pre-inter- urine in each dialysate exchange. In calculating Kt/Vurea,
vention data in all patients. In 1996, we embarked on the volume of distribution for urea was calculated from
the present intervention study, in which all malnourished the Watson formula for estimating total body water [14].
patients were prescribed a 25% increase in their deliv- PNA was calculated using the equation derived from
ered PD dose. During the 18-month inclusion period, all detailed nitrogen balance studies in continuous ambula-
patients treated with PD at our institution were evalu- tory PD (CAPD) patients [15]:
ated, provided they had been on treatment for at least
PNA (g/day)six months and had not suffered peritonitis within the
previous 30 days. This evaluation involved a subjective 5 [0.195 · UA (mmol/day)] 1 15.1 1 TPL (g/day)
global assessment (SGA) and the setting of a desirable
where UA is the total (urine plus dialysate) urea appear-body weight. The latter was determined either by using
ance and TPL is the total (urine plus dialysate) proteina predialysis “well weight” if documented or an “ideal”
weight derived from the NHANES tables [13]. Patients loss over 24 hours. The total creatinine appearance was
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measured and expressed as mmol/day/1.73 m2, whereas solute transfer. As glucose interferes with the assay for
creatinine in a linear fashion, concentrations for both ofPNA was normalized to actual body weight.
these solutes are measured at four hours, and the true
Dietary protein and calorie intake value for creatinine obtained by subtracting the glucose
concentration multiplied by a correction factor derivedThis was assessed by a single, experienced renal dieti-
tian who was blinded to the urea kinetic data, using a locally by our laboratory (0.47). Using this method, the
four-hour D/PCr was a highly reproducible measure ofdetailed dietary interview to establish the protein and
calorie intake at home over the previous 24 hours. Data low molecular weight solute transfer across a wide range
of values (0.45 to 0.9), in the short term (3 months orfrom this interview were analyzed by a dietetic software
package, Microdiet (Copyright University of Salford less provided there has been no clinical event such as
peritonitis or surgery), with a coefficient of variation of1983, 1988, Mark 7.10). Both dietary protein intake
(DPI) and dietary calorie intake (DCI) were normalized 3 to 5%. Normal ranges 6 95% CI for D/PCr were 0.635 6
0.25 and net ultrafiltration was 498 6 409 mL.for actual and ideal body weights, as described previously
in this article. This method of assessing protein and calo-
Calories derived from peritoneal glucose absorptionrie intake was carefully evaluated in this unit and was
validated by an independent dietitian working with a Data from the PET provide an accurate and repeat-
able assessment of the peritoneal fractional absorptiondifferent group of CAPD patients and normal controls
[16]. Both methods give the same mean and range of of glucose (P-CAL), which is independent of the concen-
tration of glucose instilled in the peritoneum [23, 24]. Thevalues for both DPI and DCI, without a systematic error.
In addition, both methods for assessing DPI correlate total glucose absorption over 24 hours was calculated as
the product of the fractional glucose absorption and thewith the only objective method for measuring protein
intake in outpatients, the PNA, giving very similar corre- exchange number, volume, and concentration of glucose
used in the dialysis regime. It was assumed that thelation coefficients.
Total calorie intake was calculated by adding together overnight/long-dwell value for the fractional glucose ab-
sorption was 1.0 to account for the further equilibrationthe oral calories and those obtained from the dialysis fluid.
during the longer dwell period [25, 26]. The glucose ab-
Weight and mid-arm circumference sorption was converted into calories and expressed in
terms of the estimated dry body weight in cal/kg/day.The actual body weight on the day of clinical assess-
ment was used. The MAC was measured by one of a
Comorbid diseaseteam of experienced renal dietitians, using a standard
technique [17]. Intraobserver error between dietitians The approach to identification of significant comorbid
disease has been described previously, in which it haswas reassessed every two months and was found to be
consistently within 2 mm (,1%). been shown to predict patient survival [27, 28]. The fol-
lowing categories of active comorbid disease are: (1)
Subjective global assessment malignancy active, noncutaneous disease, for example,
myeloma, breast cancer; (2) ischemic heart disease, asSubjective global assessment, a technique validated
for the assessment of the nutritional state in PD patients, evidenced by previous myocardial infarction, angina pec-
toris, positive coronary angiography, or the presence ofwas performed as described [18]. It includes a brief medi-
cal history to establish recent changes in weight or appe- ischemic changes on the resting echocardiogram; (3) pe-
ripheral vascular disease to include distal aortic, lowertite that might reflect changes in nutrition and a physical
examination to assess muscle wasting and loss of subcuta- limb, and cerebrovascular disease; (4) left ventricular
dysfunction, defined as clinical evidence of pulmonaryneous fat [19]. A grade of “A” reflects an adequate
nutritional state, “B” mild, and “C” severe malnutrition. edema, not attributable to errors in fluid balance, and/or
left ventricular dysfunction on echocardiography; (5) di-As in the CANUSA study [4], we employed a seven-
point scale, in which a score of 6 to 7 reflects “A,” 3 to abetes mellitus (types 1 and 2); (6) systemic collagen
vascular disease, for example, vasculitis, rheumatoid ar-5 grade “B,” and 1 to 2 grade “C” [20].
thritis, and systemic sclerosis; (7) other significant pathol-
Peritoneal equilibration test ogy, for example, chronic obstructive airways disease,
cirrhosis. The overall score for comorbid disease is ex-The PET was used to measure peritoneal kinetics, and
this was performed as described previously [21, 22]. Briefly, pressed as the median number of these conditions.
a standard four-hour dwell period was used (first ex-
Karnofsky score and hospital anxiety andchange of the day), using a 2.27% glucose concentration
depression scales2 L volume exchange. The dialysate:plasma ratio of cre-
atinine at the completion of the four-hour dwell period Physical functioning was measured with a modified
version of the generic 11-point Karnofsky Performance(D/PCr) was used as the estimate of low molecular weight
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Status scale (KPS) [29], which has been applied in several smaller MAC measurements, whereas the self-selected
Group 3 patients were substantially heavier, with a bodystudies of PD patients [1, 30, 31]. A score of 80 to 100
reflects normal patient activity, with no need for special mass index indicating obesity. The median number of
comorbid conditions was not statistically significant be-care, 50 to 70 a varying amount of assistance needed,
but ability to manage most personal needs, and a score of tween groups.
There were highly significant differences in solute ki-40 or less inability to care for self, requiring institutional
support. Mood state was measured with the hospital netics and dietetic assessments between patients in
Group 2 and the intervention groups. Malnourished pa-anxiety and depression (HAD) scale [32], a generic 14-
point scale divided into subscales representing features tients were characterized as having lower Kt/Vurea be-
cause of the lack of residual renal function, lower PNAof anxiety and depression. Scores of 0 to 7, 8 to 10, and
11 to 21 indicate none, borderline, and significant ratings and creatinine appearance, and a poorer appetite for
both calories and protein. Patients in Group 3 also hadfor anxiety or depression, respectively. The scale has
been used to measure mood state in previous studies of lost residual renal function and had worse solute kinetics,
which were emphasized by normalization to their actualrenal patients [33, 34].
body weight. In contrast, plasma albumin was signifi-
Analytical methods cantly lower in only Group 1 malnourished patients.
There were no significant differences in plasma bicar-Plasma and dialysate concentrations of urea, creati-
nine, and glucose were determined on an automated bonate, anxiety and depression scores, or achieved dial-
ysis ultrafiltration between groups. However, total fluiddiscrete random access analyzer (DAX 72; Bayer Instru-
ments, Basingstoke, UK). Urine and dialysate total pro- losses were significantly greater in Group 2 because of
the preservation of residual renal function. Peritonealtein estimations were made using the biuret method.
Plasma albumin levels were measured using the Bromo- solute transport was higher in the intervention groups,
but not significantly.cresol green method.
Statistical analysis Analysis of the intervention
All patients offered an increase in their dialysis doseData are presented as means, or median values when
nonparametric, as indicated in Tables 1 and 2. The cross- accepted. The increase in delivered dialysis dose in
Groups 1 and 3 was achieved by an increase in the totalsectional comparison between groups (1 to 3) at the
time of enrollment into the study was performed using volume of dialysis utilized per day of 28.6%. This was
associated with a similar increase in the total volume ofanalysis of variance for parametric data and the Kruskal–
Wallis test for nonparametric data. Longitudinal analysis dialysate effluent, 28.9%.
In Group 1, the majority of patients had an increaseof the intervention was confined to Group 2, using a paired
t-test or Mann-Whitney test (nonparametric), as there in their dwell volumes by 0.5 L. In 12 individuals, either
because they were unable to tolerate larger volumes orwere insufficient numbers in Group 3 to perform mean-
ingful statistics. Analysis of the intervention demonstrated were already using 2.5 L exchanges (N 5 2), ambulatory
peritoneal dialysis (APD) was used. These patients werethat whereas the intended increase in delivered dialysis
dose was 25% for all patients, the actual achieved in- more likely to be high-solute transport patients, and in
only two cases was an additional daytime exchange used.crease was variable. A secondary analysis of the interven-
tion was therefore performed in which linear regression The mean increase in delivered Kt/Vurea in this patient
Group was 0.33 (P , 0.0001; Table 2), and this was notwas used to correlate the changes in outcome variables
with the achieved increase in delivered dialysis dose. significantly different between CAPD and APD patients.
There was a small drop in urine output during the course
of the study, but this did not prevent there being a sig-
RESULTS
nificant increase in total Kt/Vurea, 0.29 (P , 0.001). There
Between group comparison at baseline was, however, a variable response in individual patients
to the intervention, with the range in actual rather thanThe between-group comparison of all variables at
baseline is summarized in Table 1. Patients in the two intended delivered Kt/Vurea being 20.24 to 10.9. This
variability was due to a combination of changes in bodyintervention groups were older and had been on PD on
average 18 months longer than well-nourished patients weight, affecting V, and the unpredictability of the inter-
vention on urea clearance, particularly in those patients(Group 2). Malnourished patients were twice as likely
to die during the six-month intervention period when switching to APD.
In Group 3 patients, presumably because of their rela-compared with adequately nourished patients, but tech-
nical failure was not different between groups. The actual tively large size, the ability to tolerate increased dialysis
volumes meant that APD was not required. The achievedweight and MAC measurements were different between
all three groups. Malnourished patients were lighter with increase in delivered Kt/Vurea was on average only 0.2 in
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Table 1. Comparison of demographic, nutritional, and dialytic variables between groups on entry to the study
Group 1 Group 2 Group 3 ANOVAb
Variable (Malnourished) (Nourished) (Symptomatic) (P value)
Number of patients 48 93 12
Age 60.464.5 53.663.7a 60.566.6 0.049
Sex ratio M:F 60:40 53:46 75:25 NS
Months on PD
Mean 33.7610 17.663.6a 37.2620 0.0007
Median 19.5 (6–76) 9 (6–43)a 29.2 (6–71) 0.002
Weight kg 66.864.2 70.363.2a 87.069 0.0007
MAC cm 27.261.3 29.260.8a 32.261.4 0.0006
Body mass index 24.361.4 26.161.1a 30.662.2 0.0017
Body surface area m2 1.7360.04 1.7660.04 1.9660.12a 0.007
Comorbid score
Mean 1.160.3 0.7960.2 0.9160.7 0.26
Median 1 (0–3) 0 (0–2) 0.5 (0–2) 0.17
Deaths during follow-up 7 (14.6%)a 5 (5.4%) 1 (8.3%) 0.04
Transfers to HD 2 (10.4%) 11 (11.8%) 1 (8.3%) NS
Transplants 1 (2.0%) 4 (4.3%) 0 NS
Kt/Vurea
Peritoneal 1.5160.08 1.5860.07 1.3860.16a 0.09
Total 1.6860.07 2.3660.14a 1.4860.12 0.0001
Plasma urea mmol/L 19.061.8 19.261.1 26.664.8a 0.0003
Plasma creatinine lmol/L 912688 812666 1202693a 0.0002
Plasma albumin (g/L) 31.560.86a 36.561.1 36.761.3 ,0.0001
Plasma CO2 (mmol/L) 27.661.1 27.760.9 26.862.6 0.73
nPNA (g/kg/day) 0.8160.06 0.9460.04a 0.8460.12 ,0.0001
DPI (g/kg/day) 0.8560.12 1.0260.08a 0.6960.14 0.0008
DCI (cals/kg/day) 26.463.0 31.862.2a 22.864.0 0.0014
Creatinine appearance (mmol/day/1.73 m2) 6.060.6 9.661.1a 7.461.4 ,0.0001
Peritoneal solute transport (D/PCr at 4 hours) 0.6960.03 0.6660.02 0.6960.06 0.22
SGA (7 point scale)
Mean 4.160.16a 6.160.26 6.060.9 ,0.0001
Median 4 (2–5)a 7 (4–7) 7 (3–7) ,0.0001
Karnovsky score median 80 (50–100) 90 (70–100) 85 (70–95) 0.115
In-patient days median
Previous six months 0 (0–24) 0 (0–14) 0 (0–8) 0.62
Subsequent six months 0 (0–19) 0 (0–23) 0 (0–13) 0.32
HAD depression score median 6 (1.5–15.5) 6 (1–12) 3.5 (1–11) 0.33
HAD anxiety score median 6.5 (1–13) 5.5 (0–12) 4 (1–12.5) 0.48
Mean values are 695% Confidence Interval.
Median values are (10–90) percentile range.
aDifferent to both other groups, Fisher’s LSD test (P , 0.05)
bKruskall Wallis test for nonparametric data
this group (13%), but because of an continued loss in Longitudinal nutritional changes before and
residual renal function, the overall change in Kt/V was after intervention
not significant. It can be seen from the data presented in Table 2 and
Two other aspects of the intervention were analyzed: Figures 1 and 2 that the nutritional condition of patients
the effect on achieved ultrafiltration and the number of in Group 1 had been deteriorating over the 12 months
calories absorbed from the dialysate. As indicated earlier prior to intervention. They had lost body weight, either
in this article, the net increase in delivered dialysis vol-
muscle or fat, as indicated by their declining MAC mea-
ume and drained dialysis volume was identical. There
surements throughout this period (Fig. 1), supported by awas no difference following intervention in the total net
drop in creatinine appearance. Their appetite for proteinultrafiltration or the total fluid losses, including urine
and calories had also declined, again supported by theiroutput, during the six-month follow-up period (Table
urea kinetics. Throughout this time, there had been a2). This was because of the decision not to change the
progressive loss in residual renal function. Of interest,prescription of the glucose concentrations in the dialysis
despite stable comorbidity scores and peritoneal mem-regimes. This, combined with no significant alteration in
brane function, their plasma albumin had also declinedperitoneal solute transport during the study resulting
significantly (Fig. 2). The nutritional decline was still pres-in a stable fractional absorption of glucose, meant that
ent and highly significant, even when patients who diedincreases in the peritoneal glucose load were propor-
during the follow-up period were excluded from the anal-tional to the increase in volumes. This was, as would be
anticipated, highly statistically significant (P , 0.0001). ysis. These nonsurvivors had significantly worse nutri-
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Fig. 1. Longitudinal changes in mid-arm circumference (MAC; mean
values 6 SE) before and after inclusion in the study, expressed as
percentage from baseline—the MAC equivalent to desirable body
weight—indicated by the horizontal interrupted line. Symbols are: (j)
Group 1; (h) Group 2; (s) Group 3.
Fig. 2. Longitudinal changes in the mean plasma albumin (6 SE) be-
fore and after inclusion in the study. Symbols are: (j) Group 1; (h)
Group 2; (s) Group 3. Data for patients in Group 1 are also shown
for those with (d) and without (m) comorbidity.
tional parameters 12 months prior to intervention, which
remained poor throughout the preintervention period.
Following the intervention, a change in the progressive
decline in nutrition was observed (Table 2). There was
initially a nonsignificant continued fall, followed by stabi-
lization of the weight and MAC (an increase in the ap-
pearance of creatinine at 6 months; Fig. 1). Although
the mean protein intake, as measured by PNA, or dietary
interview increased, this was not statistically significant.
There was, however, a significant increase in reported
dietary calorie intake, despite the increase in calories
obtained from peritoneal absorption. There were also
changes observed in the plasma albumin, with a further
drop occurring during the first two months after interven-
tion, followed by a significant rise by six months. This
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initial fall was seen regardless of comorbid disease,
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Table 3. Analysis of intervention in a subgroup of malnourished patients (Group 2) without comorbid disease (N 5 16)
Inclusion/
Treatment/nutritional variable 212 Months intervention P a value 12 Months 16 Months P b value
Peritoneal Kt/Vurea weekly 1.4160.08 0.4360.12 0.63 1.9460.16 ,0.001
Total Kt/Vurea weekly 1.9460.34 1.6960.18 0.04 1.9460.16 ,0.001
Total creatinine appearance mmol/day 8.362.8 7.0961.2 0.08 8.161.4 0.005
PNA g/kg/day 0.9260.14 0.8460.11 0.004 0.9160.14 0.028
DPI g/kg/day 1.060.14 0.960.12 0.09 1.060.1 0.14
Oral calories cal/kg/day 28.766.6 26.464.8 29.663.4 0.12
Plasma albumin g/day 34.662.9 31.661.9 0.045 30.862.4 34.562.6 0.01
All values are mean 6 SE.
aPaired t-test comparing values 12 months prior to inclusion
bPaired t-test comparing values before and after intervention
Fig. 4. Correlation between the change in Kt/Vurea following interven-
tion and the change in plasma albumin (r 5 0.35, P 5 0.04).Fig. 3. Correlation between the change in Kt/Vurea following interven-
tion and the change in oral calorie intake (r 5 0.46, P 5 0.007).
was observed (Figs. 3 and 4, respectively). No significant
correlation was found with any other of the outcomewhereas the subsequent rise was confined to those pa-
variables and achieved increase in dialysis dose.tients without comorbidity (Fig. 2). Malnourished pa-
There were not sufficient numbers of patients in Group 3tients without comorbidity tended to be younger (55.6
to permit meaningful statistical analysis. Patients in Groupvs. 62.8 years, P 5 0.22), on dialysis longer (median of
2 had no significant changes in any of the measured35 vs. 14.5 months, P 5 0.09), and have higher SGA
scores (4.5 vs. 3.8, P 5 0.04) when compared with those variables throughout the study period, with well-main-
with comorbid disease, whereas weight and MAC were tained residual renal function. The contemporary longi-
identical. Further analysis of this subgroup of patients tudinal changes for MAC and plasma albumin are shown
with no comorbidity (N 5 16) revealed significant postin- in Figures 1 and 2, respectively, to allow comparison.
tervention increases in PNA, as well as albumin, and
nonsignificant increases in oral calorie and protein intake
DISCUSSION(Table 3).
This study set out to establish what happens to mal-No significant longitudinal changes were observed in
nourished patients on PD if the delivered PD dose isperitoneal kinetics, anxiety and depression scores, Kar-
increased. It is a detailed description of an interventionnofsky score, or hospital admission rates. There was a
rather than a controlled study that sets out to test asignificant worsening of SGA in the 12 months prior
hypothesis. Although the latter study design would haveto intervention, which then remained stable. Prior to
been desirable from a scientific standpoint, there wereintervention, there was a small significant rise in plasma
a number of reasons as to why it was not adopted. First,bicarbonate before intervention, followed by a similar
there were ethical concerns in randomizing patients torise in the mean value postintervention, but this was not
a therapy arm that was clearly failing, in a climate inquite significant.
which increased dialysis doses were being recommendedThe changes observed in plasma albumin and oral
[6, 7]. Second, we were aware at the outset that APDcalorie intake were correlated with the achieved increase
in Kt/Vurea. In both cases, a significant positive correlation was going to be needed to achieve increased dialysis
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doses in some individuals, and randomization to thera- tion, which was performed prospectively, is seen when
pies that have a major impact on lifestyle is notoriously all the other variables were compared between Groups
difficult. Third, the purpose of randomization would 1 and 2 in this whole dialysis population. Indices of body
have been devalued by the open nature of the treatments. composition (actual body weight, MAC, and creatinine
It is hard for the patient to avoid noticing that the dialysis appearance), of appetite (PNA, dietary assessment of
dose has been increased, and the concern that this could protein and calorie intake) and visceral protein status
have influenced dietary intake would have remained. (plasma albumin) were all significantly worse in these
Finally, we would have required a much larger study patients. The differences in intake are even more marked
population. This is not to say that a study should not be if the problem of normalizing to actual rather than desir-
embarked upon, and data from the present study will able body weight is taken into account [35]. In keeping
contribute to the design of such a study in the future. with previous cross-sectional and longitudinal studies,
In our attempts to offset the limitations of a descriptive undernutrition was associated with a longer time on
study design, we adopted the following approaches in treatment and a loss of residual renal function [3, 4].
planning our investigation. We studied a whole PD popu- Furthermore, the short-term survival of these patients
lation, with no exclusions during a defined period, to was significantly worse. An interesting aspect of this
ensure that our results could be generalized to all mal- study was the clear evidence from the longitudinal data
nourished patients. We maximized the preintervention that nutrition had been declining for at least 12 months
period, which demonstrates that the decline in nutrition prior to inclusion. It can be reasonably assumed, there-
prior to intervention was not just a short-term dip in fore, that the patients identified for intervention (Group
nutritional state that might be expected to correct itself 1) had established undernutrition, both in absolute and
anyway, but an established deterioration over 12 months. relative terms.
Finally, we described our definition of undernutrition There were also important ways in which the malnour-
prospectively and approached each patient on an “inten- ished patients did not differ from the adequately nour-
tion to treat” basis. By defining both the patient popula- ished patient group. Perhaps the most surprising of these
tion and the intervention carefully, it was hoped that was the lack of significant difference in their median
useful information regarding both the feasibility and ef- comorbid disease score. Our approach to scoring comor-
fects of increasing delivered dialysis dose in malnour- bidity, which takes into account up to seven comorbid
ished patients would be forthcoming. disease states, is a powerful predictor of patient survival
Our cut-off to define poorly nourished PD patients in our hands [28] and is more comprehensive than that
employed two thresholds, an SGA grade of B or worse used in other clinical outcome studies [1, 36, 37]. We
and being 5% or more below desirable body weight. We
also found in a previous cross-sectional study that the
chose the SGA because it is a well-established technique
presence of severe comorbidity, three conditions orin PD patients [3] that predicts clinical outcome indepen-
more, was associated with a worse appetite than in thosedently of solute clearances [1], and it is familiar to many
patients with intermediate scores (1 to 2), despite a simi-clinicians. The weakness of this method in assessing nu-
lar dialysis dose [27]. One likely explanation of the lack oftrition is that the B grade is too broad, including rela-
a clear association between comorbidity and nutritionaltively well-nourished individuals who score low on recent
state in the present study is that there are relatively fewhistory alongside more significantly malnourished patients
patients with severe comorbidity. This was the experi-with established muscle wasting. It is important to recog-
ence of the NECOSAD study, which used our approachnize that the SGA is weighted in favor of history (60%)
to scoring comorbid disease [31]. Although they foundover physical examination (40%). As in the CANUSA
that the presence of comorbidity was an important pre-study [1], we adopted a seven-point grading system
dictor of outcome, there were insufficient numbers ofwithin the SGA to improve the discrimination within
patients with high scores to demonstrate an additive ef-the B grade [20]. This was not validated at the start of
fect on survival. In the present study, the mean time onthe study, however, and it was felt necessary to include
dialysis in the malnourished group was 32 months, anda second, more objective measure, to avoid including
it is unlikely that many patients with multiple comorbid-patients with a temporary loss of appetite but no other
ity will survive this long on treatment. There were onlyfeature of undernutrition in the intervention group. De-
six in the malnourished group, three of whom died beforefining desirable body weight is difficult, particularly as
the intervention period was completed.it is likely that many patients on dialysis may have an
The lack of differences in plasma bicarbonate between“abnormal” premorbid weight. For the sake of consis-
groups was also of interest in the light of recent evidencetency, however, we used the patient’s well weight predi-
that acid-base status influences nutritional outcome inalysis if this was documented, and when not available,
PD patients [38]. This probably reflects the fact that allwe used the NHANES tables [13].
The validity of this approach in defining undernutri- our patients were treated with high lactate concentration
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solutions (40 mmol/L) and that calcium carbonate is the dietetic advice and support are essential components
in the successful management of malnourished dialysisphosphate binder used in our center.
We were keen to establish whether our malnourished patients. All patients on PD at our center have detailed
dietary assessments performed every six months, and thepatients were suffering from either anxiety or depression.
The median HAD scores for both anxiety and depression method we have developed for this specifically encour-
ages feedback and patient education [16]. Malnourishedin our patients were below the threshold for clinical illness
[32] and did not differ significantly between groups at patients entering this study had already had considerable
dietetic input by the time the intervention, yet their nutri-the point of intervention. It is difficult, therefore, to
invoke these problems as a significant reason for reduced tional state was still declining. This level of support was
continued but not altered during the course of the study.appetite in our patients.
The intervention in this study, an increase in the deliv- Nevertheless, it does mean that the intervention must
be viewed as a package of measures, namely increasedered peritoneal Kt/Vurea of 25%, was chosen somewhat
arbitrarily. At the time of designing the study, there was solute clearance, glucose delivery, and dietetic support.
The longitudinal changes in nutritional indices thatno clear consensus on the appropriate targets for dialysis
adequacy in PD patients, and considerable difficulties occurred in the malnourished patient group are of partic-
ular interest. As pointed out previously in this article,remain in the choice of surrogate solute and how this
should be normalized to body size. We anticipated that there were highly significant declines in all measures of
nutrition over the 12 months prior to intervention. Takenour patients would have low Kt/Vurea and that, rather
than treating to a notional clearance target, we took the in this context, a stabilization of nutritional state, rather
than a clear improvement, might be considered a favor-view that “more dialysis” is better. We chose a 25%
increase because this was small enough to be achieved, able outcome. The halt in decline of both actual weight
and MAC, combined with the increase in creatinine ap-but large enough to show an effect, being on the steep
part of the curve in any possible relationship between pearance, is certainly encouraging if this view is taken.
Furthermore, the parallel changes in these measures sug-Kt/Vurea and appetite. In retrospect, a larger increase
might have been more informative. To achieve this in- gest that the patients are not becoming increasingly fluid
loaded.crease, we prescribed a 28% increase in dialysate vol-
ume—the principle determinant of Kt/Vurea that is largely One of the arguments underpinning the relationship
between appetite and dialysis dose has been the correla-independent of peritoneal solute transport status. This
translated into a mean increase in peritoneal Kt/Vurea of tion observed between Kt/Vurea and PNA [39] and to a
lesser extent DPI [40]. In cross-sectional studies of PD22.5%. When the small changes in residual renal function
occurring during the study are taken into account, the patients, the relevance of this correlation, caused by
mathematical coupling of the data, remains almost im-net increase in total Kt/Vurea was 18%, highly significant
but less than we had intended. The problem of increasing possible to evaluate [8]. The hope that the significance
of this relationship might be judged from longitudinaland maintaining total dialysis dose in PD patients has
been experienced in previous studies, most notably that intervention studies has been mixed. Short-term, rela-
tively large increments in Kt/Vurea have resulted in sig-by Harty et al [12]. In their study, which compared two
groups over 12 months, the increase in PD dose was all nificant increases in PNA [9], but not dietary protein
intake or changes in plasma albumin, and the issue ofbut negated by the loss in residual renal function. Their
inability to show a benefit on nutritional indices may mathematical coupling is still a possible explanation [10].
In the present study, the fall in PNA and DPI prior toreflect this problem. Despite our intention to deliver an
equal increase in dialysis dose to all patients, the achieved intervention was in parallel with the loss in residual renal
function, and this remains a serious confounding factorincrease did vary significantly between individuals. This
stresses the importance of checking the actual dialysis in evaluating this relationship. Following the increase in
delivered dialysis dose, there was a nonsignificant in-dose delivered once a prescription change has been
made. A number of factors appeared to be responsible crease in both PNA and DPI. The reasons for this could
be any of the following: (1) that increasing dialysis dosefor this, including changes in peritoneal kinetics and re-
sidual renal function, variability in ultrafiltration, and in malnourished PD patients cannot improve appetite
for protein, (2) that the achieved increase in dialysischanges in body weight.
There are two additional points regarding our inter- dose, in the context of continuing loss of residual renal
function, was not sufficient to improve appetite, (3) thatvention that must be emphasized. First, it is not possible
using conventional PD fluids to increase clearances with- these patients have become relatively less catabolic, be-
cause of increased availability of calories, so reducingout increasing the peritoneal delivery of glucose-derived
calories. This issue has not been addressed by previous nitrogen appearance, (4) that there was an increase, as
evidenced by the trend and increase in patients withoutstudies assessing dialysis intervention in any detail and
does raise the concern of appetite suppression. Second, comorbidity, but that the study was underpowered. Per-
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suading malnourished patients to eat protein is, however, tion supports that of Malhotra et al, who observed an
increase in plasma albumin in younger PD patients fol-notoriously difficult, and the first explanation is perhaps
the most likely. lowing a variable increase in dialysis dose [11]. The mech-
anism of this increase is unclear, but is unlikely to beThe greatest apparent benefit observed following in-
tervention was an increase in the total number of calories due purely to fluid balance changes in view of the stable
MAC, membrane function, and ultrafiltration. Equally,consumed, derived both from dietary and peritoneal
sources. This is an important observation in that it dem- the early fall in the albumin is against this, as improved
fluid balance would be expected to have had its effectonstrates the feasibility of increasing dialysis volumes in
PD patients, with associated increases in calorie absorp- by two months.
If the observed increase in plasma albumin truly re-tion, without affecting their general appetite adversely.
This is clearly a genuine concern when increasing the flects an improvement in nutritional state, it is of interest
that this was confined to patients without cardiovasculardose in PD patients in whom abdominal fullness is often
given as a reason for poor appetite [41]. Whereas the comorbidity. Recent observations have led to the sugges-
tion that two types of malnutrition exist in the end-stagedialytic calorie load is often seen as a problem in PD
patients, because of the risk of worsening obesity, this renal failure population, according to their association
with or without the combination of inflammation andis clearly not a major concern in malnourished patients
who are significantly below their desirable weight. Are atheroma [44]. Our observations reinforce the view that
under these circumstances, comorbid disease hinders thethese additional calories likely to be of benefit? In this
regard, it is of interest that in detailed nitrogen balance potential benefits of increasing dialysis dose on the nutri-
tional state.studies of PD patients, positive balance was achieved
early in treatment in relationship to good protein and This study also established a third group of patients in
whom the dialysis dose was increased. These individualscalorie intake, whereas later on, this was confined to
calorie intake [40]. It is possible therefore that the in- were essentially self-defining, on the basis of a number
of symptoms that may be loosely defined as uremic.crease in calorie intake we observed, which was above
the threshold of 35 cals/kg recommended in Bergstro¨m’s There were, however, some common factors. They were
significantly larger than both Groups 1 and 2, had a morestudy, may have helped some of our patients improve
their nitrogen balance. Whether this was due to the dial- rapid decline in residual renal function than Group 1,
and had a normal plasma albumin. Their Kt/Vurea andysis dose increase itself, a placebo effect, or the dialytic
calorie load is difficult to determine from this study de- normalized PNA and dietary intakes were particularly
poor, in part because of their relatively large size. Itsign, and it is likely that all three played their part. How-
ever, the positive correlation between the achieved in- is tempting to speculate that these patients are in fact
developing malnutrition, but that this is hidden by theircrease of dialysis dose and appetite for calories does
suggest that the increase in dialysis is beneficial. increased fat and protein stores. Large patients survive
equally well on PD, despite their relative “underdialysis”The longitudinal changes in plasma albumin seen in
Group 1 patients were of particular interest. Plasma albu- [45], suggesting that V has a protective effect as it appears
to in the hemodialysis population [46]. There were insuf-min in PD patients is an important predictor of clinical
outcome [1, 37, 42], being influenced by peritoneal mem- ficient numbers in this group to analyze the intervention
meaningfully.brane transport status, comorbid illness, and nutritional
state [11, 43]. These factors, in turn, influence patient In summary, we have described the effects of increas-
ing delivered PD dose in a carefully defined populationoutcome, and yet are likely to cause hypoalbuminemia
by different mechanisms. These include overhydration, of malnourished PD patients. We have established that
it is feasible to increase dialysis volumes, without detri-increased peritoneal protein clearances, so-called “re-
verse acute phase response,” and an imbalance between mental effects on appetite, and have demonstrated some
modest benefits that take six months to become appar-anabolism and catabolism. The significant fall we ob-
served prior to intervention in these patients was in the ent. The study design limits the conclusions that can be
drawn regarding the mechanisms of this improvement,context of stable membrane function, comorbidity, and
fluid losses. Unfortunately, serial measures of the acute and we have argued that any approach to this difficult
problem will involve a treatment package. Furthermore,phase response were not performed in this study. Never-
theless, these data would appear to suggest that a falling the achieved increases in Kt/V were well short of DOQI
and other national recommendations, and it must be hopedplasma albumin is a feature of worsening nutrition. Two
months following intervention, there was a further fall that higher treatment targets will have a more substantial
impact on nutritional state. Our limitation of the studyin plasma albumin, prior to a significant improvement.
Again, this improvement was proportional to the achieved to six-months follow-up was in part due to the publica-
tion of these guidelines and our view that higher treat-increase in dialysis dose and was confined to those pa-
tients without significant comorbid disease. This observa- ment targets were needed. Undoubtedly for the future,
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males and females estimated from simple anthropometric measure-PD treatment should aim at preventing the development
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attempting salvage. However, this study suggests that protein equivalent of total nitrogen appearance from urea appear-
ance: Which formulas should be used? Perit Dial Int 18:467–473,improvements in the therapy are achievable.
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